BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23453766)

  • 1. Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old.
    Sundaram ME; Talbot HK; Zhu Y; Griffin MR; Spencer S; Shay DK; Coleman LA
    Vaccine; 2013 Apr; 31(16):2057-61. PubMed ID: 23453766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study.
    Sundaram ME; Meydani SN; Vandermause M; Shay DK; Coleman LA
    Nutr Res; 2014 Feb; 34(2):149-54. PubMed ID: 24461316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults.
    Talbot HK; Coleman LA; Zhu Y; Spencer S; Thompson M; Cheng PY; Sundaram ME; Belongia EA; Griffin MR
    BMC Infect Dis; 2015 Apr; 15():195. PubMed ID: 25903659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of hemagglutination inhibition antibody level in patients with influenza A H1N1].
    Shen HH; Hou J; Zhao M; Xu J; Bai BK; Zhao J; Hu Y; Mao PY; Li BA; Mao YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):270-2. PubMed ID: 23189841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model.
    Memoli MJ; Shaw PA; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Fargis S; Risos K; Powers JH; Davey RT; Taubenberger JK
    mBio; 2016 Apr; 7(2):e00417-16. PubMed ID: 27094330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 25-hydroxyvitamin d level and influenza vaccine immunogenicity in children and adolescents.
    Science M; Maguire JL; Russell ML; Smieja M; Walter SD; Loeb M
    PLoS One; 2014; 9(1):e83553. PubMed ID: 24427274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are plasma mineral levels related to antibody response to influenza vaccination in older adults?
    Kaynar AM; Nowalk MP; Lin CJ; Moehling KK; Susick M; Bakalov V; Pitt BR; Bain DJ; Ross TM; Saul SG; Raymund M; Zimmerman RK
    Hum Vaccin Immunother; 2016 Apr; 12(4):1003-8. PubMed ID: 26751915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination.
    Patel N; Penkert RR; Jones BG; Sealy RE; Surman SL; Sun Y; Tang L; DeBeauchamp J; Webb A; Richardson J; Heine R; Dallas RH; Ross AC; Webby R; Hurwitz JL
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31575021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
    Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.
    Crum-Cianflone NF; Won S; Lee R; Lalani T; Ganesan A; Burgess T; Agan BK
    Vaccine; 2016 Sep; 34(41):5040-5046. PubMed ID: 27577557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).
    Taylor DN; Treanor JJ; Strout C; Johnson C; Fitzgerald T; Kavita U; Ozer K; Tussey L; Shaw A
    Vaccine; 2011 Jul; 29(31):4897-902. PubMed ID: 21596084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response.
    Taylor DN; Treanor JJ; Sheldon EA; Johnson C; Umlauf S; Song L; Kavita U; Liu G; Tussey L; Ozer K; Hofstaetter T; Shaw A
    Vaccine; 2012 Aug; 30(39):5761-9. PubMed ID: 22796139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
    Bai Y; Shi N; Lu Q; Yang L; Wang Z; Li L; Han H; Zheng D; Luo F; Zhang Z; Ai X
    Hum Vaccin Immunother; 2015; 11(7):1648-53. PubMed ID: 26083828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.
    Yen TY; Jou ST; Yang YL; Chang HH; Lu MY; Lin DT; Lin KH; Huang LM; Chang LY
    Pediatr Blood Cancer; 2011 Dec; 57(7):1154-8. PubMed ID: 21425448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan.
    Mondini G; Braga PE; Lopes MH; Sartori AMC; Miyaji KT; Infante V; Randi BA; Timenetsky MDCST; Ferreira JCOA; Sakita NK; Precioso AR
    Rev Inst Med Trop Sao Paulo; 2018 Jul; 60():e37. PubMed ID: 30066805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly.
    Kao TM; Hsieh SM; Kung HC; Lee YC; Huang KC; Huang LM; Chang FY; Wang NC; Liu YC; Lee WS; Liu HE; Chen CI; Chen CH
    Vaccine; 2010 Aug; 28(38):6159-63. PubMed ID: 20659517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons.
    Carlock MA; Allen JD; Hanley HB; Ross TM
    PLoS One; 2024; 19(6):e0301157. PubMed ID: 38917104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.